ArticleOncotarget2016

Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.

Genevra Pillinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.